Back to search

Article

CAF-released galectin 1 mediates non-cell-autonomous resistance to ceritinib in NSCLC.

2023-07-31

Abstract excerpt

<title>Abstract</title> <p>Background Despite the advent of second and third-generation compounds targeting ALK in ALK-addicted Non-Small Cell Lung Cancer (NSCLC), this tumor remains largely incurable due to drug resistance. A variety of cell-autonomous mechanisms have been shown to mediate acquired resistance to ALK tyrosine kinase inhibitors (TKIs); however, if and how tumor stroma can drive resistance to ALK...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0c1c202-5c0c-561f-bfc8-dfe67c38de3a
DOI
10.21203/rs.3.rs-3192164/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAF-released galectin 1 mediates non-cell-autonomous resistance to ceritinib in NSCLC.DOI 10.21203/rs.3.rs-3192164/v1
Select a neighboring publication to make it the new centre.